KRAS and cancer: The PPI network for compound 6 is visualized in Figure 14A. Importantly, TP53, ATM, PTEN, BRCA1, KRAS, CTNNBB1, BRCA2, AKT1, ERBB2 and CDKN2A were identified as core compound 6 targets in cancer.